Arkolith/Insider Trading/ELVN/Form 4

Gupta Rishi

DirectorEnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Feb 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 12, 2026Grant(A)2K—$02K
Feb 12, 2026Grant(A)34K—$034K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001537370-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML